Humacyte, Inc. (HUMA) vs NRx Pharmaceuticals, Inc. (NRXP)
- Humacyte, Inc. HUMA 0.43 −2.27%
- NRx Pharmaceuticals, Inc. NRXP 2.60 −4.06%
Humacyte, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. Humacyte, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($122.1M and $117.3M). NRx Pharmaceuticals, Inc. has the higher net margin (−691.8% vs −4,448.9%) and the higher return on invested capital (0.00% vs −433.7%). Across the 15 metrics below, NRx Pharmaceuticals, Inc. leads on 11 and Humacyte, Inc. on 4.
Valuation
Profitability
| Metric | HUMA | NRXP | Biotechnology median |
|---|---|---|---|
| Gross margin | (494.58%) | 46.64% | 65.16% |
| Operating margin | (5,240.78%) | (586.15%) | 0.00% |
| Net margin | (4,448.89%) | (691.78%) | 0.00% |
| Free cash flow margin | (4,599.72%) | (609.02%) | 0.00% |
| Return on equity | (534.42%) | 131.22% | (56.36%) |
| Return on assets | (68.16%) | (120.41%) | (48.04%) |
| Return on invested capital | (433.66%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack